Session 1: The Evolving Landscape of Immune and Cellular Therapies for Multiple Myeloma (April 2022)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Read article
How to submit a successful BOPA abstract by Jennifer Laskey and Pinkie Chambers (23/02/2022)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 4: Veno-occlusive Disease; Essentials for the Clinical Pharmacist (Sinéad Connolly, Cancer Care Pharmacist, NHS Greater Glasgow and Clyde) and Collaborative Audit and Research Updates (Siobhan Smith, Bone Marrow Transplant Pharmacist, University Hospital of Wales, Cardiff)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 3: What is new in Pre- and Post-transplant Strategies for Acute Myeloid Leukaemia (Professor Charles Craddock, Queen Elizabeth Hospital, Birmingham)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 2: Joint session- Adoptive T-cell therapy for EBV-driven cancer; Clinical update and Practical considerations (Dr Sridhar Chaganti, Consultant Haematologist, Queen Elizabeth Hospital, Birmingham and Anne Black, Regional QA Specialist Pharmacist, North East and North Cumbria)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 1: How do I transplant – Allograft for sickle cell disease (Dr Ben Carpenter, Consultant Haematologist, UCLH)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Webinar 5 – Predictors of CMV reactivation and survival in adult allo-HSCT recipients by Julian Lindsay, BMT Pharmacist at Royal North Shore Hospital and Research Fellow at NCIC (15/09/2021)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Please complete the quiz to obtain your certificate
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 4 – Clinical Subgroup of Pan UK Pharmacy Working Group for ATMPs – Update on Activities and What does the future hold for ATMPs? (Sumi Gabriel, Lead Clinical Pharmacist – Specialist Haematology, Freeman Hospital, Newcastle and Alice Mason, Lead Pharmacist – Advanced Therapy Medicinal Products, The Royal Marsden NHS Foundation Trust)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 3 – New developments in GVHD prophylaxis (Professor Ronjon Chakraverty, Professor of Haematology, Oxford University)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 2 – Drug Interactions and Real Life Experience with Letermovir (Susan Firbank, Specialist Pharmacist – Cancer Services, Freeman Hospital, Newcastle and Siobhan Smith, BMT pharmacist, University Hospital of Wales, Cardiff)
You do not have access to this area. Please contact a website administrator if this is incorrect.
Session 1 – Allogenic Transplantation for CML in the TKI era (Professor Jane Apperley, Hammersmith Hospital, London) – Approval code – UK/ICLG/P/21/0020
You do not have access to this area. Please contact a website administrator if this is incorrect.